A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer

NCT00607607 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Endometrial Cancer

Interventions

DRUG: MKC-1

Sponsor

CASI pharmaceuticals, Inc.